Period of time: 2003年5期
Publisher: Elsevier
Founded in: 2000
Total resources: 5
ISSN: 1525-0016
Subject: R4 Clinical Medicine
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Molecular Therapy,volume 8,issue 5
Menu
Oncolytic adenovirus: getting there is half the battle
By Ross P.J., Parks R.J. in (2003)
Molecular Therapy,volume 8,issue 5 , Vol. 8, Iss. 5, 2003-11 , pp.By Chung Y.-L., Lee M.-Y., Wang A.-J., Yao L.-F. in (2003)
Molecular Therapy,volume 8,issue 5 , Vol. 8, Iss. 5, 2003-11 , pp.By Kanaji A., Kosuga M., Li X.-K., Fukuhara Y., Tanabe A., Kamata Y., Azuma N., Yamada M., Sakamaki T., Toyama Y., Okuyama T. in (2003)
Molecular Therapy,volume 8,issue 5 , Vol. 8, Iss. 5, 2003-11 , pp.By Sato M., Johnson M., Zhang L., Zhang B., Le K., Gambhir S.S., Carey M., Wu L. in (2003)
Molecular Therapy,volume 8,issue 5 , Vol. 8, Iss. 5, 2003-11 , pp.By Kishida T., Asada H., Itokawa Y., Yasutomi K., Shin-Ya M., Gojo S., Cui F.-D., Ueda Y., Yamagishi H., Imanishi J., Mazda O. in (2003)
Molecular Therapy,volume 8,issue 5 , Vol. 8, Iss. 5, 2003-11 , pp.By Bernt K.M., Ni S., Li Z.-Y., Shayakhmetov D.M., Lieber A. in (2003)
Molecular Therapy,volume 8,issue 5 , Vol. 8, Iss. 5, 2003-11 , pp.MLV/HIV-pseudotyped vectors: a new treatment option for cutaneous t cell lymphomas
By Thaler S., Burger A.M., Schulz T., Schnierle B.S. in (2003)
Molecular Therapy,volume 8,issue 5 , Vol. 8, Iss. 5, 2003-11 , pp.